A

Arcturus Therapeutics Holdings
D

ARCT

15.500
USD
0.68
(4.59%)
Market Closed
Volume
22,316
EPS
-2
Div Yield
-
P/E
-7
Market Cap
419,854,065
OverviewSignalsIdeasNews
Related Instruments
    A
    ACCO
    -0.13000
    (-2.39%)
    5.30000 USD
    E
    EVO
    0.08500
    (1.95%)
    4.45500 USD
    More
News

Title: Arcturus Therapeutics Holdings

Sector: Healthcare
Industry: Biotechnology
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.